Simulations Plus Reports Mixed Q4 Results, Positive Outlook

Simulations Plus Incorporated, a software company specializing in pharmaceutical research tools, reported a loss of six hundred eighty-one thousand dollars in the fiscal fourth quarter, translating to a loss of three cents per share. However, after adjusting for one-time costs, the company saw earnings of ten cents per share. For the full fiscal year, the company reported a larger loss of sixty-four point seven million dollars, or three dollars and twenty-two cents per share, with total revenue of seventy-nine point two million dollars. Looking ahead, Simulations Plus anticipates earnings to be in the range of one dollar and three cents to one dollar and ten cents per share and revenue between seventy-nine million and eighty-two million dollars for the upcoming full year.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.